BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10839459)

  • 1. Effect of vanadyl ions on calcineurin and its A subunit.
    Wei Q; Yan L
    Biol Chem; 2000 Apr; 381(4):309-12. PubMed ID: 10839459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESR study on calcineurin.
    Wei Q; Xiao F; Lu J; Zhou J
    Sci China B; 1995 Sep; 38(9):1117-22. PubMed ID: 8554679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
    Li H; Wei Q
    IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new calcineurin inhibition domain in Cabin1.
    Jang H; Cho EJ; Youn HD
    Biochem Biophys Res Commun; 2007 Jul; 359(1):129-35. PubMed ID: 17531200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Ca(2+)-binding sites in the kidney stone inhibitor glycoprotein nephrocalcin using vanadyl ions: different metal binding properties in strong and weak inhibitor proteins revealed by EPR and ENDOR.
    Mustafi D; Nakagawa Y
    Biochemistry; 1996 Nov; 35(47):14703-9. PubMed ID: 8942630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of activation of Saccharomyces cerevisiae calcineurin by Mn2+.
    Ren Y; Wang ZX; Wei Q
    Biol Chem; 2009 Nov; 390(11):1155-62. PubMed ID: 19558332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of Loop 7 for the activity of calcineurin.
    Liu P; Huang C; Wang HL; Zhou K; Xiao FX; Qun W
    FEBS Lett; 2004 Nov; 577(1-2):205-8. PubMed ID: 15527786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression, purification and characterization of Dictyostelium calcineurin A.
    Hellstern S; Dammann H; Husain Q; Mutzel R
    Res Microbiol; 1997 May; 148(4):335-43. PubMed ID: 9765812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The catalytically active domain in the A subunit of calcineurin.
    Xiang B; Liu P; Jiang G; Zou K; Yi F; Yang S; Wei Q
    Biol Chem; 2003; 384(10-11):1429-34. PubMed ID: 14669985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory interactions of calcineurin (phosphatase 2B) and calmodulin on rat hippocampal NMDA receptors.
    Rycroft BK; Gibb AJ
    Neuropharmacology; 2004 Sep; 47(4):505-14. PubMed ID: 15380369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
    Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron spin resonance of calmodulin-vanadyl complexes.
    Nieves J; Kim L; Puett D; Echegoyen L; Benabe J; Martinez-Maldonado M
    Biochemistry; 1987 Jul; 26(14):4523-7. PubMed ID: 2822096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target recognition by calmodulin: the role of acid region contiguous to the calmodulin-binding domain of calcineurin A.
    Noguchi M; Izumi Y; Yoshino H
    FEBS Lett; 2004 Aug; 573(1-3):121-6. PubMed ID: 15327986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of vanadium (IV) to the phosphatase calcineurin.
    Parra-Diaz D; Wei Q; Lee EY; Echegoyen L; Puett D
    FEBS Lett; 1995 Nov; 376(1-2):58-60. PubMed ID: 8521966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing agents mitigate protein synthesis inhibition mediated by vanadate and vanadyl compounds in reticulocyte lysates.
    Krishnamoorthy T; Sreedhara A; Rao CP; Ramaiah KV
    Arch Biochem Biophys; 1998 Jan; 349(1):122-8. PubMed ID: 9439590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of RNase A with VO3- and VO2+ ions. Metal ion binding mode and protein secondary structure.
    Purcell M; Novetta-Delen A; Arakawa H; Malonga H; Tajmir-Riahi HA
    J Biomol Struct Dyn; 1999 Dec; 17(3):473-80. PubMed ID: 10636082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory domains of CNA have different effects on the inhibition of CN activity by FK506 and CsA.
    Wang HL; Du YW; Xiang BQ; Lin WL; Wei Q
    IUBMB Life; 2007 Jun; 59(6):388-93. PubMed ID: 17613169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nonconserved N-terminus of protein phosphatase 2B confers its properties to protein phosphatase 1.
    Xie XJ; Huang W; Xue CZ; Wei Q
    IUBMB Life; 2009 Feb; 61(2):178-83. PubMed ID: 18925649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the interactions of kaempferol to calcineurin by spectroscopic methods and docking.
    Lei H; Qi Y; Jia ZG; Lin WL; Wei Q
    Biochim Biophys Acta; 2009 Aug; 1794(8):1269-75. PubMed ID: 19439201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of protein tyrosine phosphatase activity in rat liver microsomes: suppressive effect of endogenous regucalcin in transgenic rats.
    Fukaya Y; Yamaguchi M
    Int J Mol Med; 2004 Sep; 14(3):427-32. PubMed ID: 15289895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.